EDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference

EDAP (Nasdaq: EDAP) will present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on Wednesday, March 18, 2026.

Rhea-AI Summary

EDAP (Nasdaq: EDAP) will present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on Wednesday, March 18, 2026. CEO Ryan Rhodes will deliver a virtual presentation and, with CFO Ken Mobeck, host one-on-one investor meetings from 12:00–12:30 PM ET. A live and archived webcast is available.

Argus Mar 10 session

+4.77% close to close Open Argus

Details

News Market Reaction – EDAP

On Mar 10, the day this news came out, EDAP closed 4.77% above the previous close.

Data tracked by StockTitan Argus for the Mar 10 session.

Market Context

This announcement highlights EDAP’s continued visibility with institutional investors through partic...

Analysis

This announcement highlights EDAP’s continued visibility with institutional investors through participation in the Oppenheimer healthcare conference on March 18, 2026, featuring a virtual presentation and 1x1 meetings. It follows recent milestones including preliminary record HIFU revenue and an FDA 510(k) clearance. Investors tracking the story may focus on how management’s messaging at such events aligns with previously issued 2026 guidance and upcoming detailed 2025 financial results.

Key Figures

Conference date: March 18, 2026 Presentation time: 12:00–12:30 PM ET

Conference date

March 18, 2026

Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Presentation time

12:00–12:30 PM ET

Scheduled virtual presentation window

Historical Context

5 past events · Latest: Mar 04

5 events

1. Mar 04

   Earnings date notice

   24h Move

   +6.5%

   Announced timing for Q4 and full-year 2025 financial results release.

2. Feb 12

   Board change

   24h Move

   -2.6%

   Appointed David Horn to Board and announced Glen French’s departure.

3. Jan 12

   Prelim revenue, guidance

   24h Move

   +11.4%

   Reported preliminary record 2025 HIFU revenue and issued 2026 revenue guidance.

4. Nov 20

   Regulatory clearance

   24h Move

   +5.8%

   Received FDA 510(k) clearance for upgraded Focal One HIFU imaging and workflow.

5. Nov 18

   Conference appearance

   24h Move

   +3.4%

   Announced presentation and 1x1 meetings at Piper Sandler healthcare conference.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

EDAP to Present at Oppenheimer 36^th Annual Healthcare MedTech & Services Conference

Company to Present and Host 1x1 Investor Meetings on Wednesday, March 18^th, 2026

AUSTIN, Texas, March 10, 2026 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to present and, together with Ken Mobeck, Chief Financial Officer, will host 1x1 investor meetings at the upcoming Oppenheimer 36^th Annual Healthcare MedTech & Services Conference.

Date: Wednesday, March 18^th

Time: 12:00-12:30 PM ET

Format: Virtual Presentation and 1x1 investor meetings

Webcast:https://event.summitcast.com/view/2MZVg3DCx8a3zxe3mMMekq/6YGp8gAgsNuJhACXjn75JB

The live and archived webcast of the presentation can be accessed in the Investors section of the Company’s website here.

About EDAP TMS SA

A recognized leader in robotic energy-based therapies, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics and precise non-invasive energy delivery, EDAP introduced the Focal One^® in Europe and in the U.S. as the leading prostate focal therapy controlled by urologists with the potential to expand to multiple indications beyond prostate cancer. For more information on the Company, please visit https://focalone.com/.

Investor Contact
Investor Relations
EDAP TMS SA
Investor.Relations@focalone.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will EDAP (Nasdaq: EDAP) present at the Oppenheimer Healthcare MedTech & Services Conference?

EDAP will present on Wednesday, March 18, 2026 at 12:00–12:30 PM ET. According to the company, the session is a virtual presentation with one-on-one investor meetings led by CEO Ryan Rhodes and CFO Ken Mobeck.

How can investors watch the EDAP (EDAP) presentation on March 18, 2026?

Investors can view a live webcast and archived replay via the conference link and the company investor site. According to the company, the webcast is available at the provided summitcast URL and in EDAP's Investors section for later access.

Who from EDAP (EDAP) will attend investor meetings at the Oppenheimer conference?

CEO Ryan Rhodes and CFO Ken Mobeck will host one-on-one investor meetings during the event. According to the company, both executives will present and meet with investors in virtual 1x1 sessions on March 18, 2026.

What is the format and duration of EDAP's (EDAP) conference presentation on March 18, 2026?

The presentation is a virtual session with a 30-minute scheduled window from 12:00–12:30 PM ET, plus 1x1 investor meetings. According to the company, the webcast will be available live and archived for later viewing.

Where will EDAP (Nasdaq: EDAP) post the archived webcast of its Oppenheimer presentation?

The archived webcast will be posted in EDAP's Investors section on the company website and via the conference webcast link. According to the company, both the live and archived streams will be accessible to investors after the presentation.